Lactobacillus johnsonii (Ljo) N6.2 has been shown to mitigate the development of type 1 diabetes when administered to diabetes-prone rats. The specific mechanisms underlying this observed response remain under investigation. The objective of this study was to assess the effect of Ljo N6.2 on mucosal inflammatory response using differentiated Caco-2 monolayers. The mRNA expression levels of CCL20, CXCL8, and CXCL10 chemokines were determined by qRT-PCR. Ljo These results are in agreement with the polarizing-tolerizing mechanism recently described in which the apical stimulation of TLR9 in intestinal epithelial cells leads to a higher state of immunologic alertness. Furthermore, these results suggest that live probiotics could be, in the future, replaced with select cellular components.
Introduction
The intestinal mucosal surface is a primary component of the host defense against potentially harmful microorganisms. Simultaneously, this surface is also the location where the intestinal microbiota and the host coexist in a tightly regulated balance. This symbiotic relationship is maintained through microbial recognition and tolerance by host cells. Intestinal epithelial cells (IEC) 6 play an active role in the modulation of the innate immune system. IEC release chemokines that aid in the development of gut-associated lymphoid tissues. IEC can sense microorganisms or their components through membrane-bound pattern recognition receptors [or Toll-like receptors (TLR)] and/ or cytoplasmic nucleotide-binding oligomerization domain (NOD)-like receptors. TLR expressed in epithelial cells recognize a wide variety of microbial compounds. NOD1 and NOD2 receptors sense peptidoglycan constituents and can elicit different protective or inflammatory pathways in the gut-associated lymphoid tissues. Host identification of microbial components is vital for the development of innate and adaptive immune responses to gastrointestinal infections. Furthermore, both innate receptors and microbes have been identified as important players in the balance between the induction and prevention of autoimmunity in the host (1).
In a recent study, we determined that the administration of Lactobacillus johnsonii (Ljo) N6.2 to BioBreeding diabetesprone rats (BBDP) reduced the incidence of type 1 diabetes (2). The feeding of this microorganism postweaning was followed by changes in the native microbiota, host mucosal proteins, and oxidative stress response. Lower levels of the proinflammatory cytokines, IFNg and TNFa, were also observed in the Ljo-fed group. Based on these observations, we hypothesized that Ljo-IEC interactions induce modifications in the host cell signaling pathways, altering the ability of the immune system to react to a later insult. The aims of this study were to elucidate the early effects of Ljo on the innate immune response and to determine the signaling pathways involved.
A diverse array of strain-specific microbe-host interactions has been described for Lactobacillus species (3). The information on prevention or reduction of mucosal inflammation through probiotic-IEC interactions is scarce and model specific. Recently, more attention has been placed on TLR in epithelial cells and the pathways modulated thereafter. In this study, we used the enterocyte-like Caco-2 cell line to study the specific effect of Ljo on TLR signaling pathways and their role in establishing a tolerizing environment as a means to prevent an overactive inflammatory response conducive to disease development.
Materials and Methods
Bacterial preparations. Ljo N6.2 isolated from BioBreeding diabetesresistant rats (Biomedical Research Models) was cultured as described in Lai et al. (4) . Cells grown for 24 h were centrifuged at 7400 3 g for 20 min at 48C, washed twice with sterile PBS, and resuspended in sterile PBS buffer. Aliquots containing 1 3 10 11 to 4 3 10 12 CFU/L were stored at 2808C until use. Chromosomal DNA extraction of Ljo DNA was performed using a DNeasy Blood and Tissue kit (Qiagen).
Ljo cell-free extracts were prepared by collecting cultures by centrifugation at 7400 3 g for 10 min. Cells were washed with ultrapure water 3 times. Cells were resuspended in ultrapure water to an OD 600 = 1.2 and incubated at 378C for 4 h. The supernatant was collected after centrifugation at 7400 3 g for 20 min at 48C and stored at 2808C.
Caco-2 cell culture and stimulation. Caco-2 cells were obtained from American Type Culture Collection and grown in a humidified incubator at 378C under 5% CO 2 , 95% air. Caco-2 cells were collected by dissociation of a confluent stock culture with 0.25% trypsin and 0.53 mmol/L EDTA (Mediatech). Cells were seeded onto 24-well plates (Corning). Full culture media consisted of minimum essential medium (Mediatech) supplemented with 15% FBS, 200,000 units/L penicillin, 200 mg/L streptomycin, and 50 mg/L amphotericin B (Invitrogen). Media was renewed 3 times/wk. Full confluency was reached after 1 wk and experiments were initiated on d 15-21 after seeding. Previous studies in our laboratory have shown that cells are differentiated, corresponding to the upper crypt-lower villus stage of differentiation, 15 d after seeding (5) . On the day of the experiment, monolayers were rinsed once with PBS and treated with Ljo N6.2. Bacterial stocks were centrifuged at 2600 3 g for 7 min at 48C and cell pellets were resuspended in minimum essential medium. Ljo was added to the Caco-2 cells at 10 To determine whether stimulation with Ljo could prevent or exacerbate further inflammatory insults, the effect of the known proinflammatory mediator TNFa was determined. When required, 10 mg/L of TNFa (R&D Systems) was added to the wells 1 h after bacterial treatment. In experiments lasting for 24 h, antibiotics were added after 5 h of incubation to prevent bacterial growth. After 5 or 24 h, the medium was collected for ELISA and the cells were collected in RNAzol RT (Molecular Research Center). All groups were performed in triplicate in at least 3 independent experiments.
IL-8 determination. Supernatants of culture media were collected and frozen at 2208C for determination of the concentrations of IL-8 (OptEIA, PharMingen) by ELISA as recommended by the manufacturer. IL-8 levels were normalized to standard protein concentrations.
Quantitative real-time PCR studies. To assess the effect of Ljo N6.2 on the host innate immune system, the transcript levels of select mediators and receptors were determined by qRT-PCR. RNA was isolated from Caco-2 cells 5 h after treatment with bacteria or bacterial components using RNAzol RT (Molecular Research Center). DNase 1 treatment, cDNA synthesis, and qRT-PCR were carried out as previously described (2). The primer sequences used for qRT-PCR are described in Supplemental Table 1 (6-16). The number of cycles obtained for each gene were normalized by subtracting the number of cycles obtained for the internal control (GAPDH gene) under each condition.
Transepithelial resistance measurements. Caco-2 cells were seeded onto 24-well Biocoat Cell Culture Inserts (Collaborative Biomedical Products) for transepithelial electrical resistance (TER) measurement at 200,000 cells/well. On d 21 after seeding, 10 11 CFU/L Ljo N6.2, or media alone, was added to the apical side of the monolayer. To determine the effect of the probiotic strain on TNFa-induced epithelial barrier dysfunction, TNFa (10 mg/L) was added to the basolateral side of the cells. After 5 and 24 h of incubation time, TER across the monolayer was measured. Measurements were expressed in Vcm 2 after subtracting mean values for resistance obtained from cell-free inserts and expressed as percent change in TER.
Rat experiment. Weaned BBDP rats (Biomedical Research Models) were administered suspensions of 10 8 CFU of Ljo N6.2 (n = 10) or PBS control (n = 10) daily by oral gavage. All rats consumed ad libitum a standard nonpurified diet (Harlan 7912 Irradiated Rodent Diet, 19.1% crude protein, 5.8% fat, 44.3% available carbohydrate, 4.6% crude fiber) and water. Rats were killed at 141 d of age. Small intestine samples were harvested and rinsed with PBS at 48C. Small intestine samples were fixed in 10% buffered formalin for 24 h for light microscopy analysis or preserved in RNAlater (AMBION) for qRT-PCR analysis.
Paneth cell counting. Paneth cells in the distal small intestines were evaluated in BBDP rats administered Ljo (2). Hematoxylin and eosinstained slices of the Ljo-fed group (healthy rats, n = 5) and control group (healthy rats, n = 4) were screened for number of Paneth cells per crypt and granule number per Paneth cell. For each rat, 60 crypts were examined microscopically (31000 magnification) and the number of Paneth cells was counted. The Paneth cells, located at the base of the crypts in the small intestine, were identified based on their eosinophilic granules. The granule density of each cell was scored on a scale of 1-3, with 3 being the densest and 1 being severely depleted.
Statistical analysis.
Values presented are means 6 SD. Two-way ANOVA was used to compare effects of Ljo treatment with and without TNFa stimulation. Significant values from 2-way ANOVA were subject to Bonferroni-Dunn post hoc testing. For all other comparisons, significance was assessed using 1-way ANOVA. Tukey honest significance difference post hoc tests were conducted when significant differences resulted from 1-way ANOVA. Differences were considered significant at P , 0.05. 
Results
Chemokine expression as a result of Ljo stimulation. A 10 11 -CFU/L dose of Ljo induced a strong response in the mRNA levels of CCL20 (MIP3A), CXCL8 (IL-8), and CXCL10 (IP10) by 20-, 90-, and 4-fold, respectively (Fig. 1) . TNFa stimulation of untreated Caco-2 cells resulted in a 2-fold increase in the CXCL8 chemokine mRNA levels (Fig. 1A) . The addition of TNFa to 1 3 10 10 CFU/L Ljo-treated Caco-2 monolayers amplified CXCL8 expression 2-fold (P , 0.001), whereas incubation with 1 3 10 11 CFU/L did not exacerbate the inflammatory response. These results were confirmed by measuring IL-8 concentrations. As observed with the mRNA levels, the IL-8 concentration in Caco-2 cells without TNFa stimulation showed a significant increase that correlated with the amount of Ljo administered (Fig. 1D) . A similar trend in the induction of mRNA levels was observed for CCL20 (P , 0.001) (Fig. 1C) . CXCL10 mRNA levels also increased (P , 0.001) upon incubation with 1 3 10 11 CFU/L Ljo. The addition of TNFa induced the expression of CXCL10 in untreated Caco-2 cells or at low concentrations of Ljo (P , 0.05), whereas no significant effect was observed at higher Ljo concentrations (1 3 10 11 CFU/ L; P . 0.1). These results indicate that Ljo may prime the innate immune system when in contact with the intestinal epithelium.
Modulation of host-signaling pathways. To identify the signaling pathway(s) stimulated by Ljo, the expression of TLR or NOD-like receptors was evaluated. It was determined that the expression levels of NOD1 and NOD2 were not affected by stimulation of Caco-2 cells for up to 24 h with 1 3 10 11 CFU/L Ljo (data not shown). The expression levels of TLR2, TLR5, TLR7, and TLR9 were also analyzed. As expected, TLR5 expression was not modified by Ljo as it senses flagellin (18) . The TLR2 receptor and its mediator, Tollip, showed variable results. At the highest Ljo concentration, TLR7 and TLR9 expression was induced 4.2-and 10-fold, respectively ( Fig. 2A) .
Because TLR7 and TLR9 are involved in nucleic acid (NA) sensing (18, 19) , the effects of cell-free extracts and pure nucleic acid preparations of Ljo were tested. The mRNA levels of TLR7 and TLR9 were induced in Caco-2 cells stimulated with Ljo cellfree extracts containing nucleic acid concentrations of 3.2-4.8 mg/L (P , 0.05). Similarly, the treatment of Caco-2 cells with a pure NA extraction of Ljo (1 mg/L) showed a 4.5 6 0.7 and 6.5 6 0.9 fold increase in the expression of TLR7 and TLR9, respectively (Fig. 2B) . These results indicate that IEC sensing of DNA and/or RNA from Ljo may be involved in the observed increases in select chemokines.
The effect of inhibitors of the TLR7-TLR9 (chloroquine), PI3K (LY2940021), and p38 (SB203580) signaling pathways was assessed (Fig. 3) . In nonstimulated cells, chloroquine and SB203580 repressed the expression of TLR7 5-fold. Similarly, the stimulation of TLR7 that resulted from addition of Ljo NA was reduced in the presence of these inhibitors. On the contrary, none of the inhibitors affected the upregulation of TLR7 or TLR9 upon incubation with Ljo (Fig. 3A,B) . The TLR9 induction obtained with NA was inhibited in the presence of LY2940021 and SB203580 (P , 0.01) (Fig. 3B) .
Ljo has no effect on epithelial barrier functionality in Caco-2 cells. The effect of Ljo on epithelial barrier functionality was determined using TER. As expected, TNFa treatment caused an 8% decrease in TER through the monolayers; however, treatment with Ljo did not induce a significant change in TER in TNFa-treated or untreated cells (data not shown). The expression levels of claudin-1, claudin-2, occludin, and zonula occludens were determined after incubation with 10 10 and 10 11 CFU/L Ljo. A 3-fold increase in the expression level of zonula occludens was observed when treating cells with Ljo 10 11 cells/L, whereas no significant differences were observed for claudin-1, claudin-2, or occludin. These results are in agreement with the lack of induction of TLR2, a known inducer of tight junction proteins (20, 21) . The consequences of Ljo-induced TLR9 stimulation were studied on the expression of Frizzled 5 receptors (fzd5). These receptors bind signaling proteins in the Wnt pathway, which induces Paneth cell maturation (22) . We found that the expression of fzd5 was induced 3-fold upon stimulation with 1 3 10 11 CFU/L Ljo N6.2 after 24 h, whereas its target gene, human b-defensin-2 (hbd2), was upregulated 123-fold (P , 0.001). Similarly, the stimulation of Caco-2 cells with NA showed a 44-fold increase (P , 0.05) in hbd2 expression (Fig. 4) .
To establish a correlation between the upregulation of fzd5 and Paneth cell maturation, we analyzed slices of distal intestine of BBDP rats administered Ljo (2). The number of Paneth cells per crypt in the Ljo-fed group (4.3 6 0.13) was higher (P , 0.0001) than those in the control group (3.6 6 0.09) (Fig. 5) . Granule concentration and mRNA expression levels of defensin 6 did not differ between the 2 groups.
TLR9 induced by Ljo N6.2 upregulates expression of IFNa. Based on previous observations that TLR9 induction leads to IFNa secretion and that IFNa is an inducer of the chemokine CXCL10 (23), the mRNA expression of type-1 interferons was determined in Caco-2 cells. The mRNA level of INFa was induced 20-fold upon stimulation with Ljo (1 3 10 11 cells/L). INFb expression was induced by 9-fold. Furthermore the expression of IFN type 1-related genes, Stat1 and Interferon Regulatory Factor 7, were also upregulated (3.5-and 8.2-fold, respectively) (Fig. 6) . Pure NA were a much stronger inducer of INFb and a weaker, but significant, inducer of Stat1 (P , 0.05).
We tested the effect of chloroquine on expression of Infa, Infb, Stat1, and Irf7 during stimulation with 10 11 CFU/L Ljo. The results obtained were similar to the inhibitor effect on TLR9 and TLR7. Only Irf7 showed a 50% decrease in expression as a result of chloroquine addition, whereas Infa, Infb, and Stat1 expression was not modified.
Discussion
In the BioBreeding rat model of type 1 diabetes, we determined that continuous administration of a native strain of Ljo isolated from BioBreeding diabetes-resistant rats reduces disease development in BBDP rats (2). In this study, an in vitro approach was used to study the initial effects of Ljo N6.2 on human IEC. We determined that Ljo activates the innate immune response as evidenced by the increase in expression of CCL20 (MIP3A), CXCL8 (IL-8), and CXCL10 (IP10). A gradual response to the dose concentration of Ljo was observed. CXCL8 and CCL20 had a similar pattern of induction, whereas CXCL10 was most efficiently induced by 10 11 CFU/L. At this bacterial concentration, the proinflammatory response obtained was not exacerbated by further stimulation with TNFa. These results suggest that Ljo may promote an early activation of the immune system. This activation could improve the alertness of the host defensive system, thus preventing a subsequent strong inflammatory response. In the related species L. acidophilus, a lower proinflammatory response was induced compared with Escherichia coli. However, the downstream effects were not analyzed (7) .
It is also possible that Ljo induces the expression of CXCL10 as a defensin-like molecule, although the canonical role of CXCL10 is to attract activated Th1 cells and NK cells (24) . Cole et al. (25) reported CXCL10 defensin-like antibacterial activity. Among the inducers of CXCL10 are microbial components such as peptidoglycan and lipopolysaccharide. These cellular fractions also induce high levels of CXCL8 (26) .
The innate immune system initiates a response to microorganisms or their components via pattern recognition receptors such as TLR and NOD receptors. The activation of these receptors influences the nature of the subsequent adaptive immune response. Although many components within the signaling pathway are shared by the TLR, important consequences in gene expression are observed upon stimulation of an individual TLR (27) . The current literature describes 2 major localizations of epithelial TLR: TLR that recognize NA localized at the endosome (TLR3, TLR7, TLR8, TLR9) and TLR localized at the apical side of IEC that recognize other bacterial components (28) . To assess the signaling pathways induced by Ljo, we determined the expression levels of TLR2 (lipoproteins, peptidoglycan, and lipoteichoic acid), TLR7 (RNA), and TLR9 (nonmethylated CpG motifs in DNA) (20, 28) . The expression of NOD1 and NOD2 were also determined (29) . Interestingly, in our study, Ljo caused only the upregulation of TLR7 and TLR9 mRNA levels. The data obtained using cell-free extracts of Ljo, as well as Ljo pure NA, suggest that DNA/RNA is one of the main components of Ljo-mediated signaling. The fact that TLR2 and NOD2 receptors were not upregulated under any condition analyzed indicates that peptidoglycan is not a mediator of the observed effects.
In a previous study, Rachmilewitz et al. (30) found that TLR9 signaling mediated the antiinflammatory effects of a probiotic mix (VSL3) in a murine model of experimental colitis. Similarly, Lee et al. (31) has linked DNA stimulation to higher expression of NFkB and c-Jun N-terminal kinases in response to administration of probiotic DNA to mice. Our experiments with pathway inhibitors and pure Ljo NA indicate that the MAPK signaling pathways are involved. However, stimulation with whole Ljo cells was not interrupted by any chemical tested. Chloroquine has been described as an inhibitor of TLR9 and TLR7 signaling pathways when localized in the endosome (32, 33) . Pretreatment of Caco-2 cells with chloroquine prior to exposure to pure Ljo NA or Ljo cells did not affect TLR7 or TLR9 induction (Fig. 3) . The "polarizing-tolerizing" mechanism described by Lee et al. (34) showed that the apical localization of TLR9 triggers a tolerogenic response conducive to the maintenance of colonic homeostasis and prevention of further inflammation. Similarly, a neutral effect of chloroquine was reported (32) . Consistent with this model, we also observed upregulation of fzd5 and Hbd2, described as apical TLR9-specific genes (31) . The induction of this pathway was correlated in vivo by higher counts of Paneth cells in BBDP rats administered 10 11 CFU/L of Ljo daily.
TLR9 can also activate type 1 IFN, key players in innate immunity (35) . In our study, increased mRNA levels of IFNa and IFNb were observed. The IFN regulatory proteins IRF7 and STAT1 were also induced in response to Ljo cells or purified NA. Production of type 1 IFN leads to the activation of the JAK/ STAT signaling pathway and serves as a first line of defense against infections via immune modulator effects on dendritic cells, macrophages, T cells, and B cells. Administration of type 1 IFN has been proposed as an immunotherapeutic strategy for the treatment of autoimmune diseases such as multiple sclerosis (36) . However, the role of IFNa in diabetes type 1 development is not fully understood. A high level of IFNa can be used as a marker for viral infection, and positive correlations between patients with type 1 diabetes and high IFNa levels were reported (35) . Interestingly, the protective role of viral infections in T1D development is variable and seems to be linked to immune system maturity (37, 38) . It is tempting to speculate that TLR9-mediated responses induced by Ljo could mimic a subtle viral infection and promote a protective effect. This hypothesis needs to be tested in a rodent experimental model.
Based on the present results, it is likely that Ljo mediates induction of type 1 IFN through cell-signaling pathways requiring TLR9. As a consequence, a tolerizing effect of the IEC and a higher state of immunologic activation would be achieved. Furthermore, our results indicate that NA are one of the active components mediating these responses and suggest that live probiotics could be, in the future, replaced with cellular components.
